Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Turkova

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
AIDS (London, England)|October 29, 2024
Emerging integrase resistance in an international perinatal virtual clinicAyolola Eni-Olotu, Nicola E Mackie, Jessica Glenn, et al.
Paediatric Drugs|October 22, 2024
Optimising Paediatric HIV Treatment: Recent Developments and Future DirectionsAnne E M Kamphuis, Alasdair Bamford, Alfredo Tagarro, et al.
The Pediatric Infectious Disease Journal|July 28, 2023
Inadequate Lopinavir Concentrations With Modified 8-Hourly Lopinavir/Ritonavir 4:1 Dosing During Rifampicin-based Tuberculosis Treatment in Children Living With HIVChishala Chabala, Anna Turkova, Monica Kapasa, et al.
PLOS Global Public Health|June 17, 2026
Computer-aided detection for radiological disease severity classification on chest radiograph in children with intra-thoracic tuberculosisMegan Palmer, Ineke Derks, H Simon Schaaf, et al.
Plos Medicine|November 21, 2023
Evaluating pediatric tuberculosis dosing guidelines: A model-based individual data pooled analysisLufina Tsirizani Galileya, Roeland E Wasmann, Chishala Chabala, et al.
Viruses|September 28, 2023
Sensitive HIV-1 DNA Pol Next-Generation Sequencing for the Characterisation of Archived Antiretroviral Drug ResistanceJohannes C Botha, Matthew Byott, Moira J Spyer, et al.
The Lancet. HIV|September 10, 2019
Prioritising the most needed paediatric antiretroviral formulations: the PADO4 listMartina Penazzato, Claire L Townsend, Natella Rakhmanina, et al.
BMC Medicine|March 24, 2016
Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapyAngela M Crook, Anna Turkova, Victor Musiime, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2024
Clinical Outcomes in Children With Human Immunodeficiency Virus Treated for Nonsevere Tuberculosis in the SHINE TrialChishala Chabala, Eric Wobudeya, Marieke M van der Zalm, et al.
Trials|December 22, 2018
Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP)James A Seddon, Anthony J Garcia-Prats, Susan E Purchase, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
AIDS (London, England)|October 29, 2024
Emerging integrase resistance in an international perinatal virtual clinicAyolola Eni-Olotu, Nicola E Mackie, Jessica Glenn, et al.
Paediatric Drugs|October 22, 2024
Optimising Paediatric HIV Treatment: Recent Developments and Future DirectionsAnne E M Kamphuis, Alasdair Bamford, Alfredo Tagarro, et al.
The Pediatric Infectious Disease Journal|July 28, 2023
Inadequate Lopinavir Concentrations With Modified 8-Hourly Lopinavir/Ritonavir 4:1 Dosing During Rifampicin-based Tuberculosis Treatment in Children Living With HIVChishala Chabala, Anna Turkova, Monica Kapasa, et al.
PLOS Global Public Health|June 17, 2026
Computer-aided detection for radiological disease severity classification on chest radiograph in children with intra-thoracic tuberculosisMegan Palmer, Ineke Derks, H Simon Schaaf, et al.
Plos Medicine|November 21, 2023
Evaluating pediatric tuberculosis dosing guidelines: A model-based individual data pooled analysisLufina Tsirizani Galileya, Roeland E Wasmann, Chishala Chabala, et al.
Viruses|September 28, 2023
Sensitive HIV-1 DNA Pol Next-Generation Sequencing for the Characterisation of Archived Antiretroviral Drug ResistanceJohannes C Botha, Matthew Byott, Moira J Spyer, et al.
The Lancet. HIV|September 10, 2019
Prioritising the most needed paediatric antiretroviral formulations: the PADO4 listMartina Penazzato, Claire L Townsend, Natella Rakhmanina, et al.
BMC Medicine|March 24, 2016
Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapyAngela M Crook, Anna Turkova, Victor Musiime, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2024
Clinical Outcomes in Children With Human Immunodeficiency Virus Treated for Nonsevere Tuberculosis in the SHINE TrialChishala Chabala, Eric Wobudeya, Marieke M van der Zalm, et al.
Trials|December 22, 2018
Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP)James A Seddon, Anthony J Garcia-Prats, Susan E Purchase, et al.
Pageof 9